248 related articles for article (PubMed ID: 25660298)
1. Musculoskeletal Sarcoma: Update on Imaging of the Post-treatment Patient.
Garner HW; Kransdorf MJ
Can Assoc Radiol J; 2016 Feb; 67(1):12-20. PubMed ID: 25660298
[TBL] [Abstract][Full Text] [Related]
2. Contemporary imaging in sarcoma.
Landa J; Schwartz LH
Oncologist; 2009 Oct; 14(10):1021-38. PubMed ID: 19789392
[TBL] [Abstract][Full Text] [Related]
3. Does regular follow-up influence the survival of patients with sarcoma after recurrence? The Miri Shitrit pediatric oncology department experience.
Postovsky S; Barzilai M; Meller I; Kollander Y; Futerman B; Ben Arush MW
J Pediatr Hematol Oncol; 2008 Mar; 30(3):189-95. PubMed ID: 18376279
[TBL] [Abstract][Full Text] [Related]
4. Characteristics, diagnosis and treatment of bone and soft tissue sarcomas.
Dadia S; Grimer R
Br J Hosp Med (Lond); 2007 Nov; 68(11):589-93. PubMed ID: 18087845
[No Abstract] [Full Text] [Related]
5. Posttherapy imaging of musculoskeletal neoplasms.
Garner HW; Kransdorf MJ; Peterson JJ
Radiol Clin North Am; 2011 Nov; 49(6):1307-23, vii. PubMed ID: 22024300
[TBL] [Abstract][Full Text] [Related]
6. The role of plain radiography, computed tomography, and magnetic resonance imaging in sarcoma evaluation.
Massengill AD; Seeger LL; Eckardt JJ
Hematol Oncol Clin North Am; 1995 Jun; 9(3):571-604. PubMed ID: 7649943
[TBL] [Abstract][Full Text] [Related]
7. Follow-up of musculoskeletal tumours. 2. Metastatic disease.
Bearcroft PW; Davies AM
Eur Radiol; 1999; 9(2):192-200. PubMed ID: 10101637
[TBL] [Abstract][Full Text] [Related]
8. Follow-up of musculoskeletal tumors. I. Local recurrence.
Davies AM; Vanel D
Eur Radiol; 1998; 8(5):791-9. PubMed ID: 9601967
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis and treatment of bone and soft tissue tumors].
Fujinami S; Tajima M; Higuchi S; Yamazaki T; Mori K; Sonoda J; Shiokawa Y; Ogihara Y
Gan To Kagaku Ryoho; 1995 Jul; 22(8):987-93. PubMed ID: 7611768
[No Abstract] [Full Text] [Related]
10. Follow-up examinations for bone tumors, soft tissue tumors, and suspected metastasis post therapy. American College of Radiology. ACR Appropriateness Criteria.
Manaster BJ; Dalinka MK; Alazraki N; Berquist TH; Daffner RH; DeSmet AA; el-Khoury GY; Goergen TG; Keats TE; Newberg A; Pavlov H; Schweitzer ME; Haralson RH; McCabe JB
Radiology; 2000 Jun; 215 Suppl():379-87. PubMed ID: 11037451
[No Abstract] [Full Text] [Related]
11. Detection of local recurrent disease in musculoskeletal tumors: magnetic resonance imaging versus computed tomography.
Reuther G; Mutschler W
Skeletal Radiol; 1990; 19(2):85-90. PubMed ID: 2321049
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R
Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
[TBL] [Abstract][Full Text] [Related]
13. Fluorine-18-deoxyglucose-positron emission tomography imaging with magnetic resonance and computed tomographic correlation in the evaluation of bone and soft-tissue sarcomas: a pictorial essay.
Tewfik JN; Greene GS
Curr Probl Diagn Radiol; 2008; 37(4):178-88. PubMed ID: 18502325
[TBL] [Abstract][Full Text] [Related]
14. Update on imaging and treatment of Ewing sarcoma family tumors: what the radiologist needs to know.
Mar WA; Taljanovic MS; Bagatell R; Graham AR; Speer DP; Hunter TB; Rogers LF
J Comput Assist Tomogr; 2008; 32(1):108-18. PubMed ID: 18303298
[TBL] [Abstract][Full Text] [Related]
15. MR imaging of malignant soft-tissue tumors.
Hanna SL; Fletcher BD
Magn Reson Imaging Clin N Am; 1995 Nov; 3(4):629-50. PubMed ID: 8564687
[TBL] [Abstract][Full Text] [Related]
16. Soft tissue sarcoma: An overview.
Goldberg BR
Orthop Nurs; 2007; 26(1):4-11; quiz 12-3. PubMed ID: 17273099
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance/positron emission tomography (MR/PET) oncologic applications: bone and soft tissue sarcoma.
Partovi S; Chalian M; Fergus N; Kosmas C; Zipp L; Mansoori B; Ros PR; Robbin MR
Semin Roentgenol; 2014 Oct; 49(4):345-52. PubMed ID: 25498231
[No Abstract] [Full Text] [Related]
18. Bone and soft-tissue sarcoma: preoperative staging with fluorine 18 fluorodeoxyglucose PET/CT and conventional imaging.
Tateishi U; Yamaguchi U; Seki K; Terauchi T; Arai Y; Kim EE
Radiology; 2007 Dec; 245(3):839-47. PubMed ID: 18024454
[TBL] [Abstract][Full Text] [Related]
19. Preoperative imaging for metastasectomy.
Klippenstein DL; Lamonica DM
Surg Oncol Clin N Am; 2007 Jul; 16(3):471-92, vii. PubMed ID: 17606189
[TBL] [Abstract][Full Text] [Related]
20. Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas.
Bredella MA; Caputo GR; Steinbach LS
AJR Am J Roentgenol; 2002 Nov; 179(5):1145-50. PubMed ID: 12388489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
